Effect of an Exercise Program on Risk of Fall in a Community Dwelling Older Adults

June 12, 2018 updated by: Sara Lúcia Morgado Martins

Effectiveness of an Exercise Program for Prevention of Risk of Fall in a Community Dwelling Adults Over 55 Years

Background: Falls are a problem among the elderly population, it is known that currently about 30% of people over 65 years falls every year. The European Union estimates a cost of € 281 per inhabitant per year and a cost of € 25 billion per year for health care1 which translates into a significant economic impact. The World Health Organization2 argues that it is possible to reduce these costs through prevention and health promotion strategies. For this, it is important to raise awareness, evaluate risk factors and identify and implement intervention programs. Objective: To test the effect of an exercise program on the prevention of risk of fall. Methods: This study, which lasted 4 months, was experimental, prospective. The experimental group (EG) performed an exercise program and the control group (CG) maintained their usual routine. For the measurement and evaluation of the variables under study, were used: sociodemographic data questionnaire, self-efficacy for exercise scale, Portuguese version of the falls efficacy scale (FES), 10m walking speed (WS), Timed Up & Go test (TUG), step test and Hercules® Force Platform (static balance). A significance level of 5% (p ≤ 0.05) was considered for all comparisons.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age equal or superior to 55
  • community dwelling individuals

Exclusion Criteria:

  • comprehension deficit
  • significative heart disease
  • restrictive breath disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Experimental: Intervention group
Intervention group has been submitted to an exercise program directed to prevent and reduce fall risk

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Force Platform at 4 months
Time Frame: 0 and 4 months
Static balance
0 and 4 months
Change from baseline Timed Up&Go at 4 months
Time Frame: 0 and 4 months
Dynamic balance
0 and 4 months
Change from baseline Step test at 4 months
Time Frame: 0 and 4 months
Muscular strength, motor coordination e inferior limb's agility
0 and 4 months
Change from baseline 10-meters walking test at 4 months
Time Frame: 0 and 4 months
Walking speed
0 and 4 months
Change from baseline FES at 4 months
Time Frame: 0 and 4 months
Fear of falling related by individuals and by their Daily live activity's execution
0 and 4 months
Change from baseline Self efficacy for exercise at 4 months
Time Frame: 0 and 4 months
Self efficacy for exercise
0 and 4 months
Change from baseline Exercise program adherence at 4 months
Time Frame: 0 and 4 months
Exercise program adherence 8number of sessions)
0 and 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Anabela C Martins, PhD, IPC ESTeSC Coimbra Health School

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

January 1, 2016

Study Completion (Actual)

June 30, 2016

Study Registration Dates

First Submitted

April 18, 2018

First Submitted That Met QC Criteria

June 12, 2018

First Posted (Actual)

June 25, 2018

Study Record Updates

Last Update Posted (Actual)

June 25, 2018

Last Update Submitted That Met QC Criteria

June 12, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • hdl.handle.net/10400.26/22351

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe